Adverum Biotechnologies, Inc. (ADVM)
Market Closed
9 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
4. 36
0
0%
$
96.26M Market Cap
- P/E Ratio
- Div Yield
675,984 Volume
-1.23 Eps
$ 4.36
Previous Close Want to track ADVM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Adverum Biotechnologies, Inc. (ADVM) Statistics
Valuation metrics
Market Cap 96.26M
Enterprise value 159.14M
Trailing P/E (ttm) -0.66
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) -
Price/Book (mrq) -1.84
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.12
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 1.78
52-Week high 6.07
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 21 Mar 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.99%
Return on equity 8.73%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.11
Total debt (mrq) -
Total Debt/Equity (mrq) -1.6
Current ratio (mrq) 0.65%
Book value per share (mrq) -2.37
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
